ATE111955T1 - Herstellung von rekombinantem, menschlichem psti. - Google Patents

Herstellung von rekombinantem, menschlichem psti.

Info

Publication number
ATE111955T1
ATE111955T1 AT87309087T AT87309087T ATE111955T1 AT E111955 T1 ATE111955 T1 AT E111955T1 AT 87309087 T AT87309087 T AT 87309087T AT 87309087 T AT87309087 T AT 87309087T AT E111955 T1 ATE111955 T1 AT E111955T1
Authority
AT
Austria
Prior art keywords
production
psti
human psti
recombinant human
polypeptides
Prior art date
Application number
AT87309087T
Other languages
English (en)
Inventor
Michio Ogawa
Kenichi Matsubara
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE111955T1 publication Critical patent/ATE111955T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • E—FIXED CONSTRUCTIONS
    • E03—WATER SUPPLY; SEWERAGE
    • E03B—INSTALLATIONS OR METHODS FOR OBTAINING, COLLECTING, OR DISTRIBUTING WATER
    • E03B3/00—Methods or installations for obtaining or collecting drinking water or tap water
    • E03B3/06—Methods or installations for obtaining or collecting drinking water or tap water from underground
    • E03B3/08—Obtaining and confining water by means of wells
    • E—FIXED CONSTRUCTIONS
    • E03—WATER SUPPLY; SEWERAGE
    • E03B—INSTALLATIONS OR METHODS FOR OBTAINING, COLLECTING, OR DISTRIBUTING WATER
    • E03B3/00—Methods or installations for obtaining or collecting drinking water or tap water
    • E03B3/40—Other devices for confining, e.g. trenches, drainage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Water Supply & Treatment (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT87309087T 1986-10-14 1987-10-14 Herstellung von rekombinantem, menschlichem psti. ATE111955T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61245049A JPH0616716B2 (ja) 1986-10-14 1986-10-14 酵母におけるヒトｐｓｔｉの製造法

Publications (1)

Publication Number Publication Date
ATE111955T1 true ATE111955T1 (de) 1994-10-15

Family

ID=17127817

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87309087T ATE111955T1 (de) 1986-10-14 1987-10-14 Herstellung von rekombinantem, menschlichem psti.

Country Status (8)

Country Link
EP (1) EP0267692B1 (de)
JP (1) JPH0616716B2 (de)
KR (1) KR950010817B1 (de)
AT (1) ATE111955T1 (de)
AU (1) AU597115B2 (de)
CA (1) CA1340393C (de)
DE (1) DE3750571T2 (de)
ES (1) ES2064319T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603145B2 (en) * 1986-10-14 1990-11-08 Shionogi & Co., Ltd. Aminoglycoside phosphotransferase-proteinfusions
WO1988003171A1 (en) * 1986-10-30 1988-05-05 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
JPS6427473A (en) * 1987-07-23 1989-01-30 Mochida Pharm Co Ltd Human pancreas-secreting trypsin inhibitor and production thereof
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DE3907492A1 (de) * 1989-03-08 1990-09-13 Biotechnolog Forschung Gmbh Verfahren zur isolierung und reinigung von hpsti und hpsti-varianten
WO2020176637A1 (en) 2019-02-26 2020-09-03 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
JPS6041487A (ja) * 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド 酵母発現系でのアルフア因子配列の使用
NZ207842A (en) * 1983-04-25 1988-02-12 Chiron Corp Production of human insulin-like growth factor (igf) using cdna
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
IL77227A (en) * 1984-12-06 1992-08-18 Synergen Biolog Inc Recombinant methods for production of serine protease inhibitors and methods for isolation of same
AU603145B2 (en) * 1986-10-14 1990-11-08 Shionogi & Co., Ltd. Aminoglycoside phosphotransferase-proteinfusions
WO1988003171A1 (en) * 1986-10-30 1988-05-05 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same

Also Published As

Publication number Publication date
JPH0616716B2 (ja) 1994-03-09
EP0267692A3 (en) 1989-10-25
AU7976487A (en) 1988-04-28
EP0267692A2 (de) 1988-05-18
DE3750571T2 (de) 1995-03-30
ES2064319T3 (es) 1995-02-01
DE3750571D1 (de) 1994-10-27
EP0267692B1 (de) 1994-09-21
JPS6398397A (ja) 1988-04-28
KR880005264A (ko) 1988-06-28
AU597115B2 (en) 1990-05-24
CA1340393C (en) 1999-02-16
KR950010817B1 (ko) 1995-09-23

Similar Documents

Publication Publication Date Title
NZ222450A (en) Synthetic dna, peptide synthesis and regulation of transcription of silk like protein
ATE78294T1 (de) Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE69125769D1 (de) Nukleotidsequenz, die für ein Aussenmembran-Protein von Neisseria meningitidis kodiert und Verwendung dieses Proteins zur Herstellung von Impfstoffen
FI871908A0 (fi) Transformering av trichoderma-moegel.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
DE3884356D1 (de) Verfahren zur Herstellung von Fremdprotein in Hefe, Rekombinant DNS, Transformant.
DE69013811D1 (de) Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren.
NO177863C (no) Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer
PH30889A (en) Dna encoding equuine-gamma interferon and recombination production of equine ifn-polypeptides.
DE3855449D1 (de) DNS-Klone von menschlichem Thrombomodulin
DE3750571D1 (de) Herstellung von rekombinantem, menschlichem PSTI.
ATE185604T1 (de) Gentechnische herstellung von faktor xiiia
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
ATE95242T1 (de) Hefe-expressionssystem.
ES2059436T3 (es) Proteina de la membrana exterior f de pseudomonas aeruginosa.
DE68922891D1 (de) D-Aminosäureoxidase.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
DE3855665D1 (de) Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben
ATE173762T1 (de) Klonierung der n-methylhydantoinase
DE3783145D1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.
TW342413B (en) Novel toxins isolated from Bracon Hebetor
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee